What’s Next for Stimulus, Markets as Election Remains Undecided

Despite a presidential election that remained undecided on Wednesday, political analysts prognosticated what a Biden administration and split Congress would mean for a stimulus package, healthcare, and the markets.

As of this writing early Wednesday afternoon, a live Wall Street Journal poll showed former Vice President Joe Biden in the lead, with 238 electoral votes compared with President Donald Trump’s 214 votes. The winner needs 270 votes.

Biden has received 70 million votes, the most of any presidential candidate in U.S. history.

Several states remain too close to call, the Raymond James analysts note. “Trump is leading in the votes counted thus far in GA, MI, PA, and NC, while Biden leads in NV and WI,” the Raymond James analysts wrote. “The winner of two of the following—MI, PA, or WI—likely wins the presidency.”

Biden prevailed in Wisconsin and Maine, NBC News reported Wednesday. Just before noon, the Wisconsin Elections Commission said all the ballots had been counted and Biden won by 20,697 votes, NBC News reported.

The Trump campaign, however, said it would ask for a recount in Wisconsin; the state holds 10 electoral votes. At stake in Michigan are 16 electoral votes and in Pennsylvania, 20. Final counts in these key states “could take several days (if not weeks) to decide, and the president declared he will take this to the Supreme Court,” the analysts added.

Greg Valliere, chief U.S. strategist for AGF Investments, said in his Wednesday morning email briefing that “a big story for the financial markets” is the likelihood that the Republicans will maintain control of the Senate.

“This will lead to gridlock with the liberal House—and, as a result, market-unfriendly tax hikes could stall in 2021,” he said.

The Senate result, however, “has been obscured by the threat of litigation and uncertainty, even though the Supreme Court recently has deferred to state legislatures on issues like last night’s vote counts,” Valliere stated.

If Biden wins, “his presidency would be hamstrung” by Senate Majority Leader Mitch McConnell, R-Ky, who won reelection Tuesday, along with the Senate Republicans, Valliere opined. Biden “could toughen regulations that Trump has eased, but any major legislative accomplishments would be unlikely.”

A GOP Senate would likely “reject a massive Biden stimulus plan that the financial markets are hoping for,” Valliere continued, with Trump being able to “get a bigger package than Biden’s through Congress.” Trump “would spend lavishly next year,” Valliere added, “boosting an economy that should be shaking off the pandemic by spring.”

Columbia Threadneedle Investments said, in a Wednesday blog post, that investors should “stay focused on long-term goals and avoid emotional decisions.”

In the long run, Columbia Threadneedle said, “changes in presidential administrations rarely lead to material, fundamental changes in how the U.S. economy works, especially if Congress is divided. Consequently, the basic economic tenets that the financial markets rely on are unlikely to change, so staying focused on long-term goals remains the best course of action.”

Markets, meanwhile, “are reacting very positively to the fact that a great deal of the election uncertainty has passed. Not all of it, but at least the worst outcomes seem to have been avoided,” Brad McMillan, chief investment officer at Commonwealth Financial Network, noted in an email Wednesday.

“With no blue wave, we are likely to see the Senate remain very closely divided, which will constrain the policy options of whoever wins the presidency,” McMillan wrote. “That probably rules out any substantial activity on taxes, as well as limiting any actions to control the major tech firms. On the positive side, once the election is resolved, the political order will be set, and items such as fiscal stimulus can be negotiated. Again, the story here is that uncertainty is down significantly and will drop further once we get the final figures.”

Healthcare Outlook

Split control of Congress—with the Senate maintaining GOP control and the House ruled by the Democrats—“would likely result in a business-as-usual regulatory environment for the healthcare industry,” according to a Morningstar stock analysis released Wednesday morning. “However, we think executive orders could create mildly positive effects on the number of insured Americans with a Democrat in the White House and mildly negative effects with Republican control.”

The U.S., Morningstar wrote, “still remains in increasing-access mode, and current initiatives to expand the insured population create a spectrum of risks and opportunities, with the public option representing the major wild card.”

Based on Morningstar’s pricing estimates for the public option, “we see the potential for major changes on the individual exchanges but only minor changes in the important employer-based market even at the low end of our estimated pricing range.”

The role of private insurers in the public option “could also be a point of compromise in the legislative process, since plans from private insurers, like Medicare Advantage, could play a role,” Morningstar said.

From: ThinkAdvisor